予防ヘルスケア技術・サービスの世界市場：2025年～2033年

予防ヘルスケア技術・サービスの世界市場は、2024年に2,652億9,000万米ドルに達し、2033年までには7,815億1,000万米ドルに達すると予測され、予測期間中の2025年から2033年のCAGRは12.2%で成長する見込みです。

予防ヘルスケア技術・サービスは、現代のヘルスケアシステムにとって極めて重要な要素であり、疾病を予防し、健康状態を効果的に管理するための積極的な戦略を重視しています。このプロセスには、症状が現れる前に病気を特定するための診断ツールの活用が含まれます。画像診断、遺伝子検査、バイオマーカー検査などの治療技術は、がんや心血管疾患などの疾患の早期発見に不可欠であり、治療の成功率や生存率を大幅に向上させます。

ワクチンは、病原体を認識して闘う免疫系を訓練することにより、感染症を予防するために不可欠です。予防ワクチンと治療ワクチンの両方を投与することは、疾病の発生を抑制し、蔓延を減少させることに焦点を当てた公衆衛生イニシアチブの基本です。糖尿病、高血圧、心臓病などの慢性疾患の効果的な管理戦略は極めて重要です。これには、遠隔医療サービス、遠隔モニタリング・ツール、モバイル・ヘルス・アプリケーションによって促進される定期的なモニタリングが含まれ、患者が治療計画を遵守し、全体的な健康を維持できるようサポートします。

人工知能（AI）やウェアラブルデバイスなどの革新的な技術を取り入れることで、リアルタイムの健康モニタリングが可能になり、予防医療が強化されます。これらのツールはバイタルサイン、身体活動、その他の健康指標を追跡し、深刻な問題に発展する前に潜在的なリスクに関する貴重な洞察をヘルスケア提供者に提供します。これらの要因が、世界の予防ヘルスケア技術・サービス市場拡大の原動力となっています。

市場力学：

促進要因と抑制要因

ヘルスケア技術の革新

ヘルスケア技術の革新は、世界の予防ヘルスケア技術・サービス市場の成長を促進する重要な要因です。これらの進歩は、ヘルスケア提供を根本的に変革し、その焦点を反応的治療から予防へとシフトさせています。

AI技術は、膨大なデータセットを分析してパターンを特定し健康リスクを予測することで、診断と治療計画に革命をもたらしています。例えば、AIアルゴリズムは、がんのような疾患の初期徴候を驚くべき精度で検出することができ、ヘルスケア提供者は状態が悪化する前に予防措置を実施することができます。さらに、AIは管理業務を効率化するため、ヘルスケア専門家はより患者ケアに集中することができます。遠隔医療プラットフォーム内にAI主導の診断ツールを統合することで、精度と効率の両方が向上し、より予防的なケアへのアプローチが促進されます。

ウェアラブルデバイスは著しく進歩し、心拍数やグルコースレベルのような様々な健康指標の継続的なモニタリングを提供します。これらのデバイスは、タイムリーな介入に不可欠な潜在的な問題の早期発見を容易にすることで、個人が自分の健康をコントロールする力を与えます。ウェアラブルとヘルスケア・システムの統合により、リアルタイムのデータ共有が可能になり、個別化されたケアが強化されます。

ヘルスケア技術の革新は、ケアへのアクセスを強化し、診断精度を向上させ、ウェアラブルデバイスを通じて患者に力を与え、AIと予測分析によって個別化された介入を促進することで、世界の予防ヘルスケア技術・サービス市場を発展させるために不可欠です。これらの開発は、予防とプロアクティブケア戦略を優先する健康管理への変革的アプローチを示しています。

さらに、業界の主要企業は、この世界の予防ヘルスケア技術・サービス市場の成長を促進する革新的な発売や政府のイニシアチブを取っています。例えば、2024年12月、Fujifilm HealthcareとDr. Kutty's Healthcareの合弁会社であるNURAは、ケララ州カリカットで初のAI主導型健診センターを立ち上げました。この施設は、病気の早期発見能力を向上させることを目的としたNURAのインドヘルスケア市場への戦略的拡大における重要な一歩となります。同センターは、がんやメタボリックシンドロームの発見に重点を置き、毎日最大50人をスクリーニングするよう設計されており、将来的にはロコモティブシンドロームのスクリーニングも含める計画です。

また、Fujitsuは2024年11月、地方自治体の政策が社会に与える影響をシミュレートするための革新的なデジタルツイン技術「ポリシーツイン」の開発を発表しました。この革新的なツールは、政策立案者が意思決定を最適化できるようなデータ主導の洞察を提供することで、自治体の予防ヘルスケアサービスの有効性を高めることを目的としています。これらすべての要因が、世界の予防ヘルスケア技術・サービス市場に需要をもたらしています。さらに、デジタルヘルスソリューションの拡大に対する需要の高まりも、世界の予防ヘルスケア技術・サービス市場の拡大に寄与しています。

データセキュリティとプライバシーへの懸念

データセキュリティとプライバシーの懸念は、予防ヘルスケア技術・サービスの世界市場の成長を妨げます。予防ヘルスケアのデジタルプラットフォームへの依存度が高まるにつれ、データセキュリティと患者のプライバシーに関する懸念は著しく高まっています。機密性の高い患者情報を収集・共有するためのテクノロジーへの依存は、不正アクセスやデータ漏洩、プライバシー侵害に対する懸念を高めています。このような懸念の高まりは、ヘルスケア機関のデータ保護能力に対する消費者の著しい不信感を招き、予防医療サービスの利用を躊躇させる可能性があります。

例えば、HIPAA Journalのデータによると、2024年にはヘルスケア部門でデータ漏洩が大幅に増加し、それぞれ100万件以上の医療記録に関わる事故が13件発生しました。このうち、チェンジ・ヘルスケアの情報漏えいは、1億9,000万人近くに影響を及ぼし、史上最大の医療データ漏えい事件となりました。この事件は、ヘルスケア・データ・セキュリティの重大な脆弱性を浮き彫りにし、この分野でのサイバー攻撃の脅威がエスカレートしていることを強調しています。このように、上記の要因は世界の予防ヘルスケア技術・サービス市場の潜在的成長を制限している可能性があります。

目次

第1章 調査手法と調査範囲

第2章 定義と概要

第3章 エグゼクティブサマリー

第4章 市場力学

• 影響要因
  • 促進要因
    • ヘルスケア技術の革新
  • 抑制要因
    • データセキュリティとプライバシーに関する懸念
  • 機会
  • 影響分析

第5章 産業分析

• ポーターのファイブフォース分析
• サプライチェーン分析
• 価格分析
• 特許分析
• 規制分析
• SWOT分析
• アンメットニーズ

第6章 技術タイプ別

• 早期発見・スクリーニング技術
  • 診断画像
  • 遺伝子検査
  • バイオマーカー検査
  • その他
• 慢性疾患管理技術
  • 遠隔医療サービス
  • リモート監視ツール
  • モバイルヘルスアプリケーション
  • その他
• ワクチン
  • 予防ワクチン
  • 治療ワクチン
• 先進技術
  • 臨床意思決定支援システム（CDSS）
  • 投薬管理システム
  • 電子健康記録（EHR）システム
  • その他

第7章 サービスタイプ別

• ウェルネスプログラム
• 診断サービス
• 患者教育サービス
• その他

第8章 用途別

• がん予防・スクリーニング
• 感染症予防
• 心血管疾患の管理
• 糖尿病管理
• その他

第9章 エンドユーザー別

• ヘルスケア提供者
• ヘルスケア支払者
• その他

第10章 地域別

• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • ドイツ
  • 英国
  • フランス
  • スペイン
  • イタリア
  • その他欧州地域
• 南米
  • ブラジル
  • アルゼンチン
  • その他南米
• アジア太平洋
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋
• 中東・アフリカ

第11章 競合情勢

• 競合シナリオ
• 市況・シェア分析
• M&A分析

第12章 企業プロファイル

• Medtronic
  • 会社概要
  • 製品ポートフォリオ
    • 製品説明
    • 製品の主要業績評価指標（KPI）
    • 過去および予測の製品販売
    • 製品販売量
  • 財務概要
    • 会社の収益
    • 地域別収益分配
    • 収益予測
  • 主な発展
    • 合併と買収
    • 主な製品開発活動
    • 規制当局の承認等
  • SWOT分析
• Myriad Genetics, Inc.
• Abbott.
• Quest Diagnostics.
• Merck & Co., Inc.,
• GSK plc.
• Omnicell
• McKesson Corporation
• OMRON Healthcare
• Pfizer Inc.
• Sanofi

第13章 付録

The global preventive healthcare technologies and services market reached US$ 265.29 billion in 2024 and is expected to reach US$ 781.51 billion by 2033, growing at a CAGR of 12.2% during the forecast period 2025-2033.

Preventive healthcare technologies and services are crucial elements of contemporary healthcare systems, emphasizing proactive strategies to prevent diseases and effectively manage health conditions. This process involves utilizing diagnostic tools to identify diseases before they manifest symptoms. Techniques such as diagnostic imaging, genetic testing, and biomarker testing are vital for early detection of conditions like cancer and cardiovascular diseases, significantly enhancing treatment success rates and survival outcomes.

Vaccines are essential for preventing infectious diseases by training the immune system to recognize and combat pathogens. The administration of both preventive vaccines and therapeutic vaccines is fundamental to public health initiatives focused on controlling disease outbreaks and reducing prevalence. Effective management strategies for chronic conditions such as diabetes, hypertension, and heart disease are critical. This includes regular monitoring facilitated by telehealth services, remote monitoring tools, and mobile health applications, which support patients in adhering to treatment plans and maintaining their overall health.

The incorporation of innovative technologies, including artificial intelligence (AI) and wearable devices, enhances preventive care by enabling real-time health monitoring. These tools track vital signs, physical activity, and other health metrics, providing healthcare providers with valuable insights into potential risks before they escalate into serious issues. These factors have driven the global preventive healthcare technologies and services market expansion.

Market Dynamics: Drivers & Restraints

Innovations in Healthcare Technology

Innovations in healthcare technology are a critical driver of growth in the global preventive healthcare technologies and services market. These advancements are fundamentally transforming healthcare delivery, shifting the focus from reactive treatment to proactive prevention.

AI technologies are revolutionizing diagnostics and treatment planning by analyzing vast datasets to identify patterns and predict health risks. For instance, AI algorithms can detect early signs of diseases such as cancer with remarkable precision, enabling healthcare providers to implement preventive measures before conditions worsen. Additionally, AI streamlines administrative tasks, allowing healthcare professionals to focus more on patient care. The integration of AI-driven diagnostic tools within telehealth platforms enhances both accuracy and efficiency, promoting a more preventive approach to care.

Wearable devices have significantly advanced, offering continuous monitoring of various health metrics like heart rate and glucose levels. These devices empower individuals to take control of their health by facilitating early detection of potential issues, which is critical for timely intervention. The integration of wearables with healthcare systems enables real-time data sharing, enhancing personalized care.

Innovations in healthcare technology are essential for advancing the global preventive healthcare technologies and services market by enhancing access to care, improving diagnostic accuracy, empowering patients through wearable devices, and facilitating personalized interventions via AI and predictive analytics. These developments represent a transformative approach to health management that prioritizes prevention and proactive care strategies.

Furthermore, key players in the industry have innovative launches and government initiatives that would drive this global preventive healthcare technologies and services market growth. For instance, in December 2024, NURA, a joint venture between Fujifilm Healthcare and Dr. Kutty's Healthcare, launched its first AI-driven health screening center in Calicut, Kerala. This facility marks a significant step in NURA's strategic expansion into the Indian healthcare market, aiming to improve early disease detection capabilities. The center is designed to screen up to 50 individuals daily, focusing on the detection of cancer and metabolic syndromes, with plans to include screenings for locomotive syndrome in the future.

Also, in November 2024, Fujitsu announced the development of Policy Twin, an innovative digital twin technology designed to simulate the social impact of local government policies. This innovative tool aims to enhance the effectiveness of municipal preventive healthcare services by providing data-driven insights that enable policymakers to optimize their decisions. All these factors demand the global preventive healthcare technologies and services market. Moreover, the rising demand for the expansion of digital health solutions contributes to the global preventive healthcare technologies and services market expansion.

Data Security and Privacy Concerns

The data security and privacy concerns will hinder the growth of the global preventive healthcare technologies and services market. As preventive healthcare increasingly relies on digital platforms for personalized care, concerns about data security and patient privacy have escalated significantly. The reliance on technology for collecting and sharing sensitive patient information raises fears regarding unauthorized access, data breaches, and privacy violations. This growing apprehension has led to a notable distrust among consumers regarding healthcare organizations' ability to protect their data, potentially deterring individuals from utilizing preventive healthcare services.

For instance, according to the HIPAA Journal data stated that in 2024, the healthcare sector experienced a significant surge in data breaches, with 13 incidents involving more than 1 million healthcare records each. Among these incidents, the Change Healthcare breach emerged as the largest healthcare data breach in history, impacting nearly 190 million individuals. This incident highlights the critical vulnerabilities in healthcare data security and underscores the escalating threat of cyberattacks within the sector. Thus, the above factors could be limiting the global preventive healthcare technologies and services market's potential growth.

Segment Analysis

The global preventive healthcare technologies and services market is segmented based on technology type, service type, application, end-user, and region.

Technology Type:

The early detection and screening technologies segment is expected to dominate the global preventive healthcare technologies and services market share

The early detection and screening technologies segment holds a major portion of the global preventive healthcare technologies and services market share and is expected to continue to hold a significant portion of the global preventive healthcare technologies and services market share during the forecast period.

Early detection and screening technologies are critical for proactive healthcare management, enabling timely interventions that can significantly improve patient outcomes. These technologies assist in identifying diseases at an early stage when they are often more treatable, thereby reducing morbidity and mortality rates associated with conditions like cancer. This segment includes a range of advanced technologies and methodologies aimed at facilitating early diagnosis, particularly for chronic diseases and cancers.

Key Technologies in Early Detection and Screening include X-ray, CT, MRI, and Ultrasound. These imaging modalities are fundamental in detecting abnormalities within the body. X-rays are widely used to identify bone fractures and certain lung conditions. CT (Computed Tomography) scans provide detailed cross-sectional images of organs, aiding in the early detection of tumors.MRI (Magnetic Resonance Imaging) is particularly effective for soft tissue evaluation, making it invaluable in diagnosing conditions like brain tumors or joint disorders.

Ultrasound is often utilized for prenatal screenings and examining soft tissues. Genetic testing allows for the identification of inherited conditions that may predispose individuals to certain diseases, such as breast or colon cancer. Biomarkers serve as measurable indicators of biological processes or conditions. Tests that analyze blood or other bodily fluids to detect biomarkers can indicate the presence of diseases like cancer or diabetes before symptoms manifest.

Furthermore, key players in the industry initiatives and introducing awareness programs would propel this segment's growth in the global preventive healthcare technologies and services market. For instance, in February 2024, the National Institutes of Health (NIH) established the Cancer Screening Research Network (CSRN), a clinical trials network dedicated to evaluating new technologies for cancer screening. This initiative is part of the Biden-Harris administration's Cancer Moonshot, which aims to improve early cancer detection when treatment is often more effective. The CSRN will investigate methods to identify cancers at earlier stages, enhancing the potential for successful treatment outcomes.

Also, in December 2024, Apollo Cancer Centre introduced the LungLife Screening Program, a pioneering initiative aimed at the early detection of lung cancer through advanced low-dose computed tomography (LDCT) technology. This program is designed to identify high-risk individuals at an early stage, significantly improving the chances of successful treatment. These factors have solidified the segment's position in the global preventive healthcare technologies and services market.

Geographical Analysis

North America is expected to hold a significant position in the global preventive healthcare technologies and services market share

North America holds a substantial position in the global preventive healthcare technologies and services market and is expected to hold most of the market share.

The increasing prevalence of chronic diseases such as diabetes, cardiovascular diseases, and obesity is a significant driver of market growth. According to the Centers for Disease Control and Prevention (CDC), approximately 60% of adults in the U.S. have a chronic illness, with 40% having two or more conditions. This escalating burden necessitates effective preventive healthcare measures to manage these diseases proactively.

The aging population in North America significantly contributes to the demand for preventive healthcare services. By 2030, all baby boomers will be over the age of 65, which leads to an increased focus on preventive measures aimed at enhancing quality of life and managing age-related health issues.

Continuous innovations in healthcare technologies-including telehealth, mobile health applications, and advanced diagnostic tools (such as AI-driven imaging and genomic testing)-enhance the effectiveness and accessibility of preventive healthcare services. These advancements facilitate earlier disease detection and better management of chronic conditions.

Furthermore, in this region a major of kay players' presence, well-advanced healthcare infrastructure, investments, and awareness campaigns would drive this global preventive healthcare technologies and services market. For instance, in May 2024, Superpower, a healthcare platform dedicated to personalized and preventative medicine, successfully secured $4 million in pre-seed funding to launch its innovative platform focused on enhancing longevity-oriented healthcare in India. This virtual platform aims to simplify access for individuals seeking tailored health solutions that emphasize prevention and overall well-being.

Also, in February 2024, Henry Schein, Inc. launched the Prevention is Power campaign, a multi-year public health awareness initiative led by the Henry Schein Cares Foundation (HSCF). This campaign aims to enhance health literacy and encourage patients to engage with integrated preventive care, ultimately targeting a reduction in chronic disease prevalence and overall healthcare costs. Thus, the above factors are consolidating the region's position as a dominant force in the global preventive healthcare technologies and services market.

Asia Pacific is growing at the fastest pace in the global preventive healthcare technologies and services market share

Asia Pacific holds the fastest pace in the global preventive healthcare technologies and services market and is expected to hold most of the market share.

The rising prevalence of chronic diseases such as diabetes, cardiovascular diseases, and respiratory conditions significantly drives market growth in the APAC region. As lifestyles become more sedentary and dietary habits shift, the incidence of these diseases is increasing, necessitating effective preventive healthcare measures to manage these conditions proactively.

There is a notable increase in health awareness among consumers across APAC countries. Public health campaigns, educational initiatives, and improved access to information motivate individuals to engage in preventive healthcare practices, including regular screenings and vaccinations. This heightened awareness is crucial for fostering a culture of health and wellness.

Many governments in the APAC region are implementing policies aimed at promoting preventive healthcare. Initiatives targeting non-communicable diseases (NCDs) and funding for public health programs encourage the adoption of preventive services across various demographics, including remote areas.

Continuous advancements in healthcare technologies-including telehealth solutions, mobile health applications, and advanced diagnostic tools-enhance the accessibility and effectiveness of preventive healthcare services. These innovations enable earlier detection of diseases and better management of chronic conditions, making preventive care more efficient and user-friendly.

Furthermore, key player's strategies such as partnerships & collaborations, and innovative launches would drive this global preventive healthcare technologies and services market growth. For instance, in July 2024, Nervfit and MyCLNQ announced a strategic partnership aimed at enhancing technology-driven preventive healthcare in India. This collaboration will introduce an innovative system known as 'Technology-Enabled Care' (TEC), which merges Nervfit's expertise in wearable fitness technology with MyCLNQ's advanced health monitoring capabilities.

Also, in November 2024, Star Health Insurance, a leading health insurance provider in India, launched an innovative Corporate Social Responsibility (CSR) initiative called 'Star Arogya Digi Seva' in partnership with the Center for Chronic Disease and Control (CCDC). This innovative program aims to transform healthcare delivery in underserved communities by integrating telemedicine technology with Mobile Health Units (MHUs). Thus, the above factors are consolidating the region's position as the fastest-growing force in the global preventive healthcare technologies and services market.

Competitive Landscape

The major global players in the preventive healthcare technologies and services market include Medtronic, Myriad Genetics, Inc., Abbott., Quest Diagnostics., Merck & Co., Inc., GSK plc., Omnicell, McKesson Corporation, OMRON Healthcare, Pfizer Inc., and Sanofi among others.

Key Developments

• In January 2025, Apollo ProHealth partnered with The Hindu to launch a new initiative aimed at providing the public with actionable health insights. This program is designed to enhance early awareness of health issues and empower individuals to make informed decisions regarding their health. By focusing on preventive measures, the initiative seeks to encourage proactive health management, enabling people to recognize potential health risks and take appropriate actions to mitigate them.

Why Purchase the Report?

• Pipeline & Innovations: Reviews ongoing clinical trials, and product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
• Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
• Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
• Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
• Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
• Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
• Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
• Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
• Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
• Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
• Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
• Post-market Surveillance: Uses post-market data to enhance product safety and access.
• Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global preventive healthcare technologies and services market report delivers a detailed analysis with 60+ key tables, more than 50 visually impactful figures, and 176 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2023

• Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
• Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
• Technology & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
• Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
• Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
• Supply Chain: Distribution and Supply Chain Managers.
• Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
• Academic & Research: Academic Institutions.

Table of Contents

1. Methodology and Scope

• 1.1. Research Methodology
• 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

• 3.1. Snippet by Technology Type
• 3.2. Snippet by Service Type
• 3.3. Snippet by Application
• 3.4. Snippet by End-User
• 3.5. Snippet by Region

4. Dynamics

• 4.1. Impacting Factors
  • 4.1.1. Drivers
    • 4.1.1.1. Innovations in Healthcare Technology
  • 4.1.2. Restraints
    • 4.1.2.1. Data Security and Privacy Concerns
  • 4.1.3. Opportunity
  • 4.1.4. Impact Analysis

5. Industry Analysis

• 5.1. Porter's Five Force Analysis
• 5.2. Supply Chain Analysis
• 5.3. Pricing Analysis
• 5.4. Patent Analysis
• 5.5. Regulatory Analysis
• 5.6. SWOT Analysis
• 5.7. Unmet Needs

6. By Technology Type

• 6.1. Introduction
  • 6.1.1. Analysis and Y-o-Y Growth Analysis (%), By Technology Type
  • 6.1.2. Market Attractiveness Index, By Technology Type
• 6.2. Early Detection and Screening Technologies*
  • 6.2.1. Introduction
  • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 6.2.3. Diagnostic Imaging
  • 6.2.4. Genetic Testing
  • 6.2.5. Biomarker Testing
  • 6.2.6. Others
• 6.3. Chronic Disease Management Technologies
  • 6.3.1. Telehealth Services
  • 6.3.2. Remote Monitoring Tools
  • 6.3.3. Mobile Health Applications
  • 6.3.4. Others
• 6.4. Vaccines
  • 6.4.1. Preventive Vaccines
  • 6.4.2. Therapeutic Vaccines
• 6.5. Advanced Technologies
  • 6.5.1. Clinical Decision Support Systems (CDSS)
  • 6.5.2. Medication Management Systems
  • 6.5.3. Electronic Health Records (EHR) Systems
  • 6.5.4. Others

7. By Service Type

• 7.1. Introduction
  • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Service Type
  • 7.1.2. Market Attractiveness Index, By Service Type
• 7.2. Wellness Programs*
  • 7.2.1. Introduction
  • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 7.3. Diagnostic Services
• 7.4. Patient Education Services
• 7.5. Others

8. By Application

• 8.1. Introduction
  • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 8.1.2. Market Attractiveness Index, By Application
• 8.2. Cancer Prevention and Screening*
  • 8.2.1. Introduction
  • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 8.3. Infectious Disease Prevention
• 8.4. Cardiovascular Disease Management
• 8.5. Diabetes Management
• 8.6. Others

9. By End-User

• 9.1. Introduction
  • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  • 9.1.2. Market Attractiveness Index, By End-User
• 9.2. Healthcare Providers*
  • 9.2.1. Introduction
  • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 9.3. Healthcare Payers
• 9.4. Others

10. By Region

• 10.1. Introduction
  • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
  • 10.1.2. Market Attractiveness Index, By Region
• 10.2. North America
  • 10.2.1. Introduction
  • 10.2.2. Key Region-Specific Dynamics
  • 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology Type
  • 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Service Type
  • 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  • 10.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 10.2.7.1. U.S.
    • 10.2.7.2. Canada
    • 10.2.7.3. Mexico
• 10.3. Europe
  • 10.3.1. Introduction
  • 10.3.2. Key Region-Specific Dynamics
  • 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology Type
  • 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Service Type
  • 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  • 10.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 10.3.7.1. Germany
    • 10.3.7.2. U.K.
    • 10.3.7.3. France
    • 10.3.7.4. Spain
    • 10.3.7.5. Italy
    • 10.3.7.6. Rest of Europe
• 10.4. South America
  • 10.4.1. Introduction
  • 10.4.2. Key Region-Specific Dynamics
  • 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology Type
  • 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Service Type
  • 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  • 10.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 10.4.7.1. Brazil
    • 10.4.7.2. Argentina
    • 10.4.7.3. Rest of South America
• 10.5. Asia-Pacific
  • 10.5.1. Introduction
  • 10.5.2. Key Region-Specific Dynamics
  • 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology Type
  • 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Service Type
  • 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  • 10.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 10.5.7.1. China
    • 10.5.7.2. India
    • 10.5.7.3. Japan
    • 10.5.7.4. South Korea
    • 10.5.7.5. Rest of Asia-Pacific
• 10.6. Middle East and Africa
  • 10.6.1. Introduction
  • 10.6.2. Key Region-Specific Dynamics
  • 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology Type
  • 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Service Type
  • 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 10.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

11. Competitive Landscape

• 11.1. Competitive Scenario
• 11.2. Market Positioning/Share Analysis
• 11.3. Mergers and Acquisitions Analysis

12. Company Profiles

• 12.1. Medtronic*
  • 12.1.1. Company Overview
  • 12.1.2. Product Portfolio
    • 12.1.2.1. Product Description
    • 12.1.2.2. Product Key Performance Indicators (KPIs)
    • 12.1.2.3. Historic and Forecasted Product Sales
    • 12.1.2.4. Product Sales Volume
  • 12.1.3. Financial Overview
    • 12.1.3.1. Company Revenue's
    • 12.1.3.2. Geographical Revenue Shares
    • 12.1.3.3. Revenue Forecasts
  • 12.1.4. Key Developments
    • 12.1.4.1. Mergers & Acquisitions
    • 12.1.4.2. Key Product Development Activities
    • 12.1.4.3. Regulatory Approvals etc.
  • 12.1.5. SWOT Analysis
• 12.2. Myriad Genetics, Inc.
• 12.3. Abbott.
• 12.4. Quest Diagnostics.
• 12.5. Merck & Co., Inc.,
• 12.6. GSK plc.
• 12.7. Omnicell
• 12.8. McKesson Corporation
• 12.9. OMRON Healthcare
• 12.10. Pfizer Inc.
• 12.11. Sanofi

LIST NOT EXHAUSTIVE

13. Appendix

• 13.1. About Us and Services
• 13.2. Contact Us